title: Characterization of seven low incidence blood group antigens carried by erythrocyte band 3 protein.
abstract: Recent studies have demonstrated that band 3 carries antigens of the Diego blood group system and have elucidated the molecular basis of several previously unassigned low incidence and high incidence antigens. Because the available serological data suggested that band 3 may carry additional low incidence blood group antigens, we screened band 3 genomic DNA encoding the membrane domain of band 3 for single-strand conformational polymorphisms. We found that the putative first ectoplasmic loop of band 3 carries blood group antigen ELO, 432 Arg-->Trp; the third putative loop harbors antigens Vga (Van Vugt), 555 Tyr-->His, BOW 561 Pro-->Ser, Wu (Wulfsberg), 565 Gly-->Ala, and Bpa (Bishop), 569 Asn-->Lys; and the putative fourth ectoplasmic loop carries antigens Hga (Hughes), 656 Arg-->Cys, and Moa (Moen), 656 Arg-->His. We studied erythrocytes from carriers of five of these blood group antigens. We found similar levels of reticulocyte mRNA corresponding to the two band 3 gene alleles, normal content and glycosylation of band 3 in the red blood cell membrane, and normal band 3-mediated sulfate influx into red blood cells, suggesting that the mutations do not have major effect on band 3 structure and function. In addition to elucidating the molecular basis of seven low incidence blood group antigens, these results help to create a more accurate structural model of band 3.
authors.affiliation: Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. pjarolim@rics.bwh.harvard.edu
authors.forename: P
authors.initials: P
authors.lastname: Jarolim
authors.forename: H L
authors.initials: HL
authors.lastname: Rubin
authors.forename: D
authors.initials: D
authors.lastname: Zakova
authors.forename: J
authors.initials: J
authors.lastname: Storry
authors.forename: M E
authors.initials: ME
authors.lastname: Reid
mesh_terms: D000371:Agglutination / Q000187:drug effects; D000483:Alleles; D019943:Amino Acid Substitution; D001457:Anion Exchange Protein 1, Erythrocyte / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology; D000954:Antigens, Surface / Q000235:genetics*; D001789:Blood Group Antigens / Q000235:genetics* / Q000276:immunology; D017124:Conserved Sequence; D004912:Erythrocytes / Q000737:chemistry / Q000276:immunology; D019143:Evolution, Molecular; D006801:Humans; D009154:Mutation; D010447:Peptide Hydrolases / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D018807:Polymorphism, Single-Stranded Conformational; D012333:RNA, Messenger / Q000032:analysis; D012156:Reticulocytes / Q000737:chemistry; D017422:Sequence Analysis, DNA
chemical_list: D001457:Anion Exchange Protein 1, Erythrocyte; D000954:Antigens, Surface; D001789:Blood Group Antigens; D012333:RNA, Messenger; D010447:Peptide Hydrolases